GSK Plc is studying a large group of elderly adults in the UK to determine if its blockbuster shingles vaccine reduces the risk of dementia, potentially opening the door to an expanded label for the ...

Current health news highlights a 10% rise in child TB infections in Europe, a new drug review by European regulators, the ...

The California biotech firm said in a statement that it is hoping to find a buyer to address its ongoing financial struggles.

GSK PLC closed 18.56% short of its 52-week high of £18.24, which the company achieved on May 16th.

Barclays analyst Emily Field maintained a Hold rating on GlaxoSmithKline (GSK – Research Report) today and set a price target of £14.50. The ...

GSK on Monday said that the European Medicines Agency has agreed to review a request to approve the British drugmaker's ...